Mission and Goals
The mission of the Bone & Musculoskeletal Study Group is to conduct research and develop guidelines for the prevention and treatment of skeletal complications in patients with cancer. Skeletal complications arise as a result of both the disease and the treatments for various cancers (e.g., aromatase inhibitors and androgen-deprivation therapy). The Bone & Musculoskeletal Study Group is an interdisciplinary effort with the objective of raising awareness of the skeletal complications common in people with cancer. These complications can shorten survival and may have a significant impact on quality of life.
The objectives of this study group are to identify new targets for the prevention and treatment of bone metastases, to establish guidelines for the management of skeletal complications (such as osteonecrosis of the jaw), and the prevention of atypical fractures in patients treated with antiresorptive therapies. Further, the study group aims to improve patients’ knowledge of bone health. This group focuses on improved standards of care with respect to early identification of bone metastases, risks for osteoporosis, and early intervention. The group also serves as a resource for multicenter clinical trials and translational studies.